SG11202005327YA - Composition for improving intestinal barrier function - Google Patents

Composition for improving intestinal barrier function

Info

Publication number
SG11202005327YA
SG11202005327YA SG11202005327YA SG11202005327YA SG11202005327YA SG 11202005327Y A SG11202005327Y A SG 11202005327YA SG 11202005327Y A SG11202005327Y A SG 11202005327YA SG 11202005327Y A SG11202005327Y A SG 11202005327YA SG 11202005327Y A SG11202005327Y A SG 11202005327YA
Authority
SG
Singapore
Prior art keywords
composition
barrier function
intestinal barrier
improving intestinal
improving
Prior art date
Application number
SG11202005327YA
Inventor
Ayuta Funaki
Naoki Kasajima
Hideyuki Arie
Original Assignee
Suntory Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Holdings Ltd filed Critical Suntory Holdings Ltd
Publication of SG11202005327YA publication Critical patent/SG11202005327YA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024Esters of saccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Immunology (AREA)
  • Physiology (AREA)
  • Diabetes (AREA)
  • Polymers & Plastics (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Food Science & Technology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Mycology (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Saccharide Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SG11202005327YA 2017-12-27 2018-12-26 Composition for improving intestinal barrier function SG11202005327YA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2017251995 2017-12-27
PCT/JP2018/047840 WO2019131759A1 (en) 2017-12-27 2018-12-26 Intestinal barrier function-enhancing composition

Publications (1)

Publication Number Publication Date
SG11202005327YA true SG11202005327YA (en) 2020-07-29

Family

ID=67067415

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202005327YA SG11202005327YA (en) 2017-12-27 2018-12-26 Composition for improving intestinal barrier function

Country Status (7)

Country Link
US (1) US20200315998A1 (en)
JP (1) JP7252904B2 (en)
CN (1) CN111526735A (en)
CA (1) CA3086827A1 (en)
SG (1) SG11202005327YA (en)
TW (1) TWI778202B (en)
WO (1) WO2019131759A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111084780A (en) * 2020-01-09 2020-05-01 昆明医科大学 Application of geraniin in preparing medicine for treating osteoporosis and fracture
CN112791091B (en) * 2021-01-15 2022-04-29 江南大学 Application of cowherb seed flavonoid glycoside in improving intestinal barrier function

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60135760D1 (en) * 2000-08-01 2008-10-23 Oryza Oil & Fat Chem NIGHT CANDLE EXTRACTS AS INHIBITORS OF SUGAR ABSORPTION AND THEIR MANUFACTURING PROCESS
JP2002193819A (en) 2000-12-26 2002-07-10 Kirin Brewery Co Ltd Absorption inhibitor and drink, food or medicine containing the same
JP2004262905A (en) 2003-03-04 2004-09-24 Inabata Koryo Kk Antiallergic agent and food including the same
AT503521A1 (en) 2006-05-05 2007-11-15 Omnica Gmbh USE OF AN EXTRACT OF KIWI FRUIT
MY157650A (en) 2008-03-06 2016-07-15 Nova Lab Sdn Bhd Extract from oil palm leaves comprising phenolic acids
JP5614674B2 (en) 2009-09-18 2014-10-29 万壽美 竹元 Life-style related disease prevention and improvement agent
JP5865524B2 (en) 2015-01-09 2016-02-17 Fontec R&D株式会社 Method for producing gennoshouko composition

Also Published As

Publication number Publication date
JPWO2019131759A1 (en) 2020-12-24
TWI778202B (en) 2022-09-21
CA3086827A1 (en) 2019-07-04
TW201936065A (en) 2019-09-16
US20200315998A1 (en) 2020-10-08
JP7252904B2 (en) 2023-04-05
WO2019131759A1 (en) 2019-07-04
CN111526735A (en) 2020-08-11

Similar Documents

Publication Publication Date Title
LT3541332T (en) Ostomy barrier
IL271986A (en) Pharmaceutical composition
GB201712159D0 (en) Pharmaceutical composition
HK1231325A1 (en) Improved anti-vermin barrier
GB201515018D0 (en) Barrier
IL258243A (en) Barrier
GB201604033D0 (en) Barrier
IL271529A (en) Barrier
GB201719447D0 (en) Pharmaceutical composition
IL272419A (en) Pharmaceutical composition
SG11202005327YA (en) Composition for improving intestinal barrier function
SG11202109389UA (en) Composition for intestinal barrier function improvement
EP3727485C0 (en) Pharmaceutical composition
GB201717370D0 (en) Barrier
LT3445296T (en) Ostomy barrier
SG11202005552UA (en) Composition for improving intestinal barrier function
GB2594660B (en) Barrier
GB2565778B (en) Improved isolation barrier
GB2555529B (en) Barrier
GB201703675D0 (en) Barrier arrangement
SG11202005550QA (en) Composition for improving intestinal barrier function
CA194487S (en) Barrier
GB2567437B (en) Barrier
ZA202006468B (en) Barrier
ZA201807645B (en) Barrier